Praxis Precision Medicines News

Praxis Precision Medicine Analyst Ratings

BenzingaJun 18 18:35

Guggenheim Initiates Coverage On Praxis Precision Medicine With Buy Rating, Announces Price Target of $155

BenzingaJun 18 18:37

Praxis Precision Medicines Inc: Jefferies Raises Price Target from $128 to $141

Zhitong FinanceMay 28 15:37

Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), Corbus Pharmaceuticals (CRBP)

TipRanksMay 20 18:32

Praxis Precision Medicine Analyst Ratings

BenzingaMay 17 01:21

Buy Rating Backed by Robust Pipeline and Market Opportunity for Praxis Precision Medicines

TipRanksMay 16 16:19

Praxis Precision Medicine Analyst Ratings

BenzingaMay 14 19:44

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Bluebird Bio (BLUE) and Nuvalent (NUVL)

TipRanksMay 14 18:40

Analysts Have Conflicting Sentiments on These Healthcare Companies: Theravance Biopharma (TBPH), Voyager Therapeutics (VYGR) and Praxis Precision Medicines (PRAX)

TipRanksMay 14 10:30

Praxis Precision Medicine (PRAX.US) was first covered by Baird, which gave it an superior market rating, with a target price of $117.00.

Zhitong FinanceMay 1 17:30

Praxis Precision Medicine Analyst Ratings

BenzingaMay 1 17:23

Baird Initiates Coverage On Praxis Precision Medicine With Outperform Rating, Announces Price Target of $117

BenzingaMay 1 17:25

Praxis Precision Medicine Analyst Ratings

BenzingaApr 26 19:05

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)

TipRanksApr 26 18:20

Wedbush Trims Price Target on Praxis Precision Medicines to $40 From $41 After $200 Million Secondary Offering, Maintains Neutral Rating

MT NewswiresApr 8 22:26

Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), GlycoMimetics (GLYC)

TipRanksMar 28 20:20

Jefferies Adjusts Praxis Precision Medicines' Price Target to $128 From $75, Keeps Buy Rating

MT NewswiresMar 27 01:41

Praxis Precision Medicine Analyst Ratings

BenzingaMar 27 00:20

Buy Rating Affirmed for Praxis Precision Medicines' PRAX-628 Based on Strong Clinical Trial Outcomes and Market Potential

TipRanksMar 27 00:15

Buy Rating Affirmed for Praxis Precision Medicines Amidst Promising Pipeline and Financial Stability

TipRanksMar 11 11:25